Some would ask what does humor and lymphoma have in common? Cancer is a scary thing, not to be laughed at. Very true. But in all serious illnesses, it helps to be able to look at situations and introduce some humor into it - just to cope. The famous story is of some very sick person who got a bunch of Three Stooges movies and "laughed himself well". If it were so easy in most cases.
If you'd like to read up on humor I have a couple of suggestions. Steve Gould (who had NHL) was a very talented writer. Two of his books - "Thank God it's Only Cancer" and "A Lighter Look at the 'C' Word" I recommend mainly for adults. For a younger audience, the comic strip Luann dealt with Hodgkin's in a great way.
I encourage you to find your own way through the humor-lymphoma connection. Whether it is joking about bald heads or calling Adriamycin "Red Kool-Aid." A smile is good medicine.
And Happy Halloween from the scariest place on the planet: Washington DC :^)
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...